Mark Reisenauer reports a stock award at OBX
By AlphaYouPublished Form 4
Reisenauer Mark L
Reporting filer
Mark Reisenauer reports a stock award, not an open-market purchase or sale, in Obsidian Therapeutics, Inc.. Form 4 filed Nov 13, 2026 lists 1 entry.
- Disclosed
- Nov 13, 2026
Reported details
1 entry| Security | Owner | Date | Code | Action | Quantity | Price | Following holdings | Reporting delay | Filed terms and references |
|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) (derivative) | Reisenauer Mark L | 2026-11-10 | A | Grant or award | 75364 | 0 | 75,364 | 3 days | Filed terms
|
Stock Option (Right to Buy) (derivative)
- Owner
- Reisenauer Mark L
- Date
- 2026-11-10
- Code
- A
- Action
- Grant or award
- Quantity
- 75364
- Price
- 0
- Following holdings
- 75,364
- Reporting delay
- 3 days
- Filed terms and references
Filed terms
- security Title: Stock Option (Right to Buy)
- conversion Or Exercise Price: 13.74
- transaction Date: 2026-11-10
- deemed Execution Date:
- transaction Form Type: 4
- transaction Code: A
- equity Swap Involved: 0
- transaction Timeliness:
- transaction Shares: 75364
- transaction Price Per Share: 0
- transaction Acquired Disposed Code: A
- id: F1
- expiration Date: 2036-11-09
- underlying Security Title: Common Stock
- underlying Security Shares: 75364
- shares Owned Following Transaction: 75364
- direct Or Indirect Ownership: D
Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.
Filing context
- Quantities and prices are shown in the units filed. No trade value is inferred from their product.
- Reisenauer Mark L: Director.
- F1: The shares underlying this option shall vest and become exercisable in thirty-six equal monthly installments following November 10, 2026, subject to the Reporting Person's continued service with the Issuer on each such vesting date.
Original sources
Prepared automatically from public filing data. Report a correction.